Morphologic and molecular prognostic markers in prostate cancer

被引：29
|
作者：
Ross, JS [1 ]
Sheehan, CE
Dolen, EM
Kallakury, BVS
机构：
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Radiol, Albany, NY 12208 USA
[3] Millennium Pharmaceut Inc, Cambridge, MA USA
[4] Georgetown Univ, Sch Med, Dept Pathol, Georgetown, MD USA
来源：
ADVANCES IN ANATOMIC PATHOLOGY | 2002年 / 9卷 / 02期
关键词：
prostate cancer; biomarker; prognosis; grade; stage; DNA ploidy; cell proliferation; oncogene; cell adhesion; HER-2/neu; apoptosis; proteasome;
D O I：
10.1097/00125480-200203000-00003
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this review, a series of traditional morphology-based measurements, relatively well-documented ancillary biomarkers, and emerging molecular assays are evaluated for their relative ability to predict prognosis in prostate cancer. Prognostic factors that have achieved widespread use and are classified as category I by the College of American Pathologists' Solid Tumor Prognostic Factor Consensus Conference are compared with newer tests that are beginning to be used in clinical practice (category II) and emerging molecular-based assays that have yet to be widely validated in the published literature or in clinical trials (category III).
引用
收藏
页码：115 / 128
页数：14
相关论文
共 50 条
  • [21] Molecular prognostic markers in breast cancer
    Dahiya, R
    Deng, GR
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 185 - 200
  • [22] Prognostic significance of four molecular markers in relation to fatal prostate cancer after prostatectomy
    Weinmann, Sheila
    Hague, Reina
    Kallakury, Bhaskar
    Richert-Boe, Kathryn
    Berry, Deborah
    Van Den Eeden, Stephen
    CANCER RESEARCH, 2010, 70
  • [23] Prognostic significance of four molecular markers in relation to fatal prostate cancer after prostatectomy
    Weinmann, Sheila
    Hague, Reina
    Kallakury, Bhaskar
    Richert-Boe, Kathryn
    Berry, Deborah
    Van Den Eeden, Stephen
    CANCER RESEARCH, 2010, 70
  • [24] Molecular markers of prostate cancer outcome
    Quinn, DI
    Henshall, SM
    Sutherland, RL
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (06) : 858 - 887
  • [25] Prostate cancer: Molecular markers and prognosis
    Richards L.
    Nature Reviews Urology, 2009, 6 (7) : 347 - 347
  • [26] Relevance of Molecular Markers in Prostate Cancer
    Concato, John
    Uchio, Edward
    Wells, Carolyn K.
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (12) : 894 - 894
  • [27] Molecular markers in the diagnosis of prostate cancer
    van der Poel, H. G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (02) : 104 - 139
  • [28] Molecular markers and mortality in prostate cancer
    Concato, John
    Jain, Dhanpat
    Li, William W.
    Risch, Harvey A.
    Uchio, Edward M.
    Wells, Carolyn K.
    BJU INTERNATIONAL, 2007, 100 (06) : 1259 - 1263
  • [29] Molecular and prognostic markers in prostate cancer - A study of cell-cycle regulators, angiogenesis and candidate markers - Introduction
    Halvorsen, Ole Johan
    APMIS, 2008, 116 : 8 - 62
  • [30] Prognostic utility of various immunohistochemical markers in prostate cancer
    Millar, J
    Sheaff, M
    Feneley, M
    Baithun, SI
    JOURNAL OF PATHOLOGY, 2000, 190 : 40A - 40A
12345